EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:INCY),(NASDAQ:TNGX),(NASDAQ:RYZB),(NYSE:BMY) EQNX::TICKER_END
USA News Group – One of the more worrying storylines of 2023 was the rising incidence of early-onset pancreatic cancer. As well, the deadly disease showed pancreatic cancer rates rising faster among...
Another company's buyout helped drive up the price last week. This week, investors started out by selling the stock.
The Chart of the Day belongs to the cancer biotechnology company Tango Therapeutics (TNGX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical...
The company got the go-ahead last week from the FDA for a drug's IND.
Remember that past performance doesn't predict future returns.
The company had several announcements as part of its second-quarter earnings report.
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm The Briscoe Law Firm, PLLC are investigating potential violation of laws in connection...
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BCTG Acquisition Corp., which merged with Tango Therapeutics, Inc. ("Tango" or "the...
The clinical-stage biotech company has two candidates in its drug pipeline.